Can blood plasma help cure COVID-19?

A second effort is underway at UCI’s Vaccine R&D Center: exploring convalescent plasma therapy for COVID-19 patients. Convalescent therapy involves collecting blood plasma from recovered patients and transfusing it into an infected person. It’s believed that antibodies from a recovered patient could trigger an immune response to fight off the virus. The research team aims to determine the efficacy of convalescent plasma in treating COVID-19, as well as optimal collection timing and dosing, according to a statement.

The group is led by Concord-based Cerus Corp. (Nasdaq: CERS), with participation from the California Department of Public Health, the Vitalant Research Institute, the California National Primate Research Center and Enable Biosciences. It is currently unknown whether convalescent plasma will effectively treat COVID-19.

For the comprehensive analysis, visit